Publication | Open Access
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
26
Citations
17
References
2017
Year
Phase Ib StudyHepatologyMedicinePathologyLiver DiseaseLiver CancerOncologyRadiation OncologyHepatocellular Carcinoma
| Year | Citations | |
|---|---|---|
Page 1
Page 1